Metraipolis › archive › dc_7472ccdae28a

Nanomedicine Meets Immunotherapy: Advancing Adoptive Cell Therapy with Nanoparticles in the Treatment of Cancer with Sustainability Perspectives — Europe PMC PMID:41793185

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41793185
DOI
10.1002/advs.202522864
License (as archived)
solo-consultazione
Archived
2026-11-05T00:54:22.090Z
SHA-256 of the archived text
15bf47c32a926a48918ffb966eafc4db78650d8e6cbc36fd3fdf27b808cb5c72
Stable URL of this page
https://metraipolis.com/documento/dc_7472ccdae28a

How to cite

Nanomedicine Meets Immunotherapy: Advancing Adoptive Cell Therapy with Nanoparticles in the Treatment of Cancer with Sustainability Perspectives — Europe PMC PMID:41793185 — Europe PMC (en), https://europepmc.org/article/MED/41793185 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7472ccdae28a (Metraipolis archive dc_7472ccdae28a, sha256 15bf47c32a926a48918ffb966eafc4db78650d8e6cbc36fd3fdf27b808cb5c72)
BibTeX
@misc{dc7472ccdae28a,
  title = {Nanomedicine Meets Immunotherapy: Advancing Adoptive Cell Therapy with Nanoparticles in the Treatment of Cancer with Sustainability Perspectives — Europe PMC PMID:41793185},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41793185},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7472ccdae28a; sha256 15bf47c32a926a48918ffb966eafc4db78650d8e6cbc36fd3fdf27b808cb5c72},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41793185. Agents can read the archived copy with the MCP tool read_document.